EW - Edwards stock jumps 8% on FDA approval Wells Fargo upgrade
2024-02-02 12:20:25 ET
More on Edwards Lifesciences
- Edward Lifesciences: Still Not A Buy But Getting Closer
- Edwards Lifesciences: Undervalued With A Substantial Upside Potential
- Edwards gets FDA okay for Evoque tricuspid valve replacement system
- Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback
- Seeking Alpha’s Quant Rating on Edwards Lifesciences